273 related articles for article (PubMed ID: 36183479)
1. The clinical features of juvenile dermatomyositis: A single-centre inception cohort.
Cancarini P; Nozawa T; Whitney K; Bell-Peter A; Marcuz JA; Taddio A; Guo J; Dover S; Feldman BM
Semin Arthritis Rheum; 2022 Dec; 57():152104. PubMed ID: 36183479
[TBL] [Abstract][Full Text] [Related]
2. Juvenile Dermatomyositis: Advances in Pathogenesis, Assessment, and Management.
Leung AKC; Lam JM; Alobaida S; Leong KF; Wong AHC
Curr Pediatr Rev; 2021; 17(4):273-287. PubMed ID: 33902423
[TBL] [Abstract][Full Text] [Related]
3. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.
Rider LG; Shah M; Mamyrova G; Huber AM; Rice MM; Targoff IN; Miller FW;
Medicine (Baltimore); 2013 Jul; 92(4):223-243. PubMed ID: 23877355
[TBL] [Abstract][Full Text] [Related]
4. Clinical profile of anti-NXP-2 antibody-positive inflammatory myositis and outcome in an Indian population.
Manwatkar A; Padiyar S; Nair A; Jha A; Kumar S; Yadav B; Prakash JAJ; Das JK; Mathew J
Clin Rheumatol; 2023 Dec; 42(12):3289-3297. PubMed ID: 37801141
[TBL] [Abstract][Full Text] [Related]
5. Juvenile dermatomyositis with Anti-SAE antibodies in a Moroccan child associated with pseudo-angioedema: a case report.
Nainia K; Aouzal MA; Ouafik I; Charhbili M; Bouchhab A; Daoudi A; Tizki S; Chakiri R
Pediatr Rheumatol Online J; 2024 May; 22(1):57. PubMed ID: 38773611
[TBL] [Abstract][Full Text] [Related]
6. Juvenile dermatomyositis associated with autoantibodies to small ubiquitin-like modifier activating enzyme: a report of 4 cases from North India and a review of literature.
Vignesh P; Barman P; Basu S; Mondal S; Ishran B; Kumrah R; Dod A; Garg R; Rawat A; Singh S
Immunol Res; 2023 Feb; 71(1):112-120. PubMed ID: 36278969
[TBL] [Abstract][Full Text] [Related]
7. Clinical Characteristics and Course of Patients with Juvenile Dermatomyositis - Case Series.
Rajarathinam I; Raghuram J; Rao AP
Neurol India; 2022; 70(1):300-303. PubMed ID: 35263900
[TBL] [Abstract][Full Text] [Related]
8. Juvenile dermatomyositis: a tertiary center experience.
Barut K; Aydin PO; Adrovic A; Sahin S; Kasapcopur O
Clin Rheumatol; 2017 Feb; 36(2):361-366. PubMed ID: 28058540
[TBL] [Abstract][Full Text] [Related]
9. Juvenile dermatomyositis in Thai children: Retrospective review of 30 cases from a tertiary care center.
Nitiyarom R; Charuvanij S; Likasitwattanakul S; Thanoophunchai C; Wisuthsarewong W
Indian J Dermatol Venereol Leprol; 2022; 88(2):162-170. PubMed ID: 34491668
[TBL] [Abstract][Full Text] [Related]
10. Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features.
Troyanov Y; Targoff IN; Payette MP; Raynauld JP; Chartier S; Goulet JR; Bourré-Tessier J; Rich E; Grodzicky T; Fritzler MJ; Joyal F; Koenig M; Senécal JL
Medicine (Baltimore); 2014 Nov; 93(24):318-332. PubMed ID: 25500701
[TBL] [Abstract][Full Text] [Related]
11. Angioedema-like presentation as the presenting finding of juvenile myositis and juvenile dermatomyositis in 2 patients.
Karaca Ö; Güngör M; Sakarya Güneş A; Eser Şimşek I; Anık Y; Kara B
Int J Rheum Dis; 2022 May; 25(5):617-625. PubMed ID: 35238477
[TBL] [Abstract][Full Text] [Related]
12. [Dermatomyositis and juvenile dermatomyositis].
Dressler F; Maurer B
Z Rheumatol; 2023 Apr; 82(3):233-245. PubMed ID: 35486206
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the biomarkers related to the clinical course and outcomes of juvenile dermatomyositis.
Lin TW; Hu YC; Chiang BL
J Microbiol Immunol Infect; 2023 Apr; 56(2):416-423. PubMed ID: 36572597
[TBL] [Abstract][Full Text] [Related]
14. Juvenile Dermatomyositis.
Rhim JW
J Rheum Dis; 2022 Jan; 29(1):14-21. PubMed ID: 37476697
[TBL] [Abstract][Full Text] [Related]
15. The family impact of caring for a child with juvenile dermatomyositis.
Kountz-Edwards S; Aoki C; Gannon C; Gomez R; Cordova M; Packman W
Chronic Illn; 2017 Dec; 13(4):262-274. PubMed ID: 28133992
[TBL] [Abstract][Full Text] [Related]
16. [Juvenile dermatomyositis: A series of 22 cases].
Moegle C; Lipsker D
Ann Dermatol Venereol; 2020 Sep; 147(8-9):494-503. PubMed ID: 32532518
[TBL] [Abstract][Full Text] [Related]
17. The clinical phenotypes of the juvenile idiopathic inflammatory myopathies.
Shah M; Mamyrova G; Targoff IN; Huber AM; Malley JD; Rice MM; Miller FW; Rider LG;
Medicine (Baltimore); 2013 Jan; 92(1):25-41. PubMed ID: 23263716
[TBL] [Abstract][Full Text] [Related]
18. Muscle MRI at the time of questionable disease flares in Juvenile Dermatomyositis (JDM).
Abdul-Aziz R; Yu CY; Adler B; Bout-Tabaku S; Lintner KE; Moore-Clingenpeel M; Spencer CH
Pediatr Rheumatol Online J; 2017 Apr; 15(1):25. PubMed ID: 28403889
[TBL] [Abstract][Full Text] [Related]
19. Anti-Mi-2 and Anti-TIF1-γ Double-Positive Juvenile Dermatomyositis Treated under Diagnosis of Chronic Eczema: A Case Report.
Yoshida S; Matsumoto H; Fujita Y; Yokose K; Temmoku J; Matsuoka N; Yashiro-Furuya M; Asano T; Sato S; Suzuki E; Yago T; Yaguchi T; Aita T; Kusano M; Yamamoto T; Watanabe H; Migita K
Tohoku J Exp Med; 2022 Apr; 256(4):303-308. PubMed ID: 35296571
[TBL] [Abstract][Full Text] [Related]
20. The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)--clinical characteristics of children recruited within the first 5 yr.
McCann LJ; Juggins AD; Maillard SM; Wedderburn LR; Davidson JE; Murray KJ; Pilkington CA;
Rheumatology (Oxford); 2006 Oct; 45(10):1255-60. PubMed ID: 16567354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
